GOSS
Gossamer Bio Inc
10.90$
-0.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | -127.5% | – | – | – | – | – | – | – | – | |
| – | -7.5% | -2.0% | +0.6% | +10.7% | -2.1% | -68.2% | -37.7% | +3.3% | +3.2% | +2.2% | -98.3% | – | |
| – | -2.1% | -3.7% | -13.9% | -3.2% | +2.5% | -51.6% | +7.5% | +3.1% | +8.7% | +117.5% | -60.9% | – | |
| – | +1,146.8% | -1,634.7% | – | -106.4% | – | – | – | – | -211.1% | – | -535.2% | – | |
| – | +100.0% | -100.0% | – | -72.5% | -100.0% | – | +103.8% | -100.0% | – | – | – | – | |
| – | -87.9% | – | -195.8% | -54.7% | – | -58.5% | +100.0% | -61.4% | +330.0% | -43.1% | +2.6% | – | |
| – | – | +351.9% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -101.5% | -12.0% | +260.6% | – | -100.0% | – | -81.3% | +1,891.5% | +111.3% | -87.1% | -714.1% | – | |
| – | -210.7% | – | +610.9% | -221.7% | – | -196.8% | – | – | – | -88.6% | -96.4% | – | |
| – | – | – | – | -127.5% | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.